QC
ABCL icon

Quadrature Capital’s AbCellera Biologics ABCL Stock Holding History

Quadrature Capital’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Sell
37,972
-167,123
-81% -$601K ﹤0.01% 1189
2025
Q4 		$701K Buy
+205,095
New +$916K 0.01% 609
2025
Q2 		– Sell
-14,584
Closed -$32.4K – 1003
2025
Q1 		$32.4K Sell
14,584
-21,872
-60% -$62.7K ﹤0.01% 1010
2024
Q4 		$107K Sell
36,456
-23,161
-39% -$64.5K ﹤0.01% 913
2024
Q3 		$154K Buy
59,617
+45,688
+328% +$127K ﹤0.01% 809
2024
Q2 		$41.4K Buy
+13,929
New +$52.7K ﹤0.01% 1080

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return